Contact

Slow Ledger 2 Home About Services What Is Ibogaine Risks & Screening Research & Legal Map Contact A careful starting point Start Here: An Ibogaine Information Hub This ibogaine information hub is for people asking serious questions about a high-risk, investigational treatment: what it is, what research can and cannot say, and why safety context matters before every other claim. Evidence first. No sourcing advice, dosing instructions, or promises. Orientation What is ibogaine Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant, native to Central Africa. The scientific overview of this iboga alkaloid describes a compound with complex effects on the central nervous system. It is often discussed in relation to opioid addiction and other forms of drug addiction because some people report reduced acute withdrawal and drug cravings after an experience. Those reports do not establish ibogaine as proven addiction treatment, and they do not remove the need for medical supervision. The language and street names around ibogaine can obscure important distinctions between a plant, an alkaloid, an unregulated service, and an investigational drug. Clear language is a basic form of harm reduction. Ibogaine is not FDA-approved addiction treatment in the united states. Potential therapeutic benefits remain under study, while potential risks are established and can be severe. A careful discussion starts with evidence, legal status, screening, and patient safety. Context before claims The history and origin of ibogaine Ibogaine has a cultural history that deserves more care than a simple pharmacology summary can provide. Plant and place The iboga plant and Tabernanthe iboga are associated with Central-West Africa. For centuries, Bwiti spiritual traditions in Gabon and Cameroon have used iboga in ceremonial practices connected to healing and spiritual exploration. Background on iboga plants can help distinguish the bot

Contact

Independent, careful, limited in scope.